New and Emerging Treatments for Obstructive Hypertrophic Cardiomyopathy (oHCM)
Obstructive Hypertrophic Cardiomyopathy (oHCM) treatment is shifting from invasive surgeries to targeted pharmacotherapy. The emergence of cardiac myosin inhibitors like mavacamten and aficamten, alongside upcoming SGLT2 inhibitors and sarcomere modulators, ... Read More